Related Experiment Video

Updated: Sep 25, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Paediatric tuberculosis

W Hoskyns1

  • 1debra.delbridge@uhl-tr.nhs.uk

Postgraduate Medical Journal
|June 5, 2003
PubMed

Insights

Pediatric tuberculosis (TB) is crucial for tracking disease spread and future transmission. Children infected with TB face a higher risk of developing active disease, necessitating effective diagnostic and treatment strategies.

Area of Science:

  • Pediatric infectious diseases
  • Epidemiology of tuberculosis
  • Molecular genetics of Mycobacterium tuberculosis

Background:

  • Children are key indicators of recent tuberculosis transmission.
  • Pediatric tuberculosis carries a higher risk of progression to active disease.
  • Standard diagnostic tools include chest radiography and tuberculin testing.

Purpose of the Study:

  • To summarize the current understanding of pediatric tuberculosis.
  • To highlight challenges in diagnosis and treatment.
  • To discuss future directions in vaccine development.

Main Methods:

  • Review of existing literature on pediatric tuberculosis epidemiology.
  • Analysis of standard diagnostic approaches.
  • Discussion of current treatment protocols and challenges.
  • Exploration of the role of BCG vaccination.
  • Consideration of advancements in molecular genetics.

Main Results:

  • Children serve as important markers for tuberculosis epidemiology.
  • Higher risk of disease progression in infected children.
  • Established treatment protocols exist, but challenges remain.
  • Multidrug-resistant tuberculosis and HIV co-infection complicate management.
  • BCG vaccine's role remains debated.
  • Molecular genetics offers potential for improved vaccines.

Conclusions:

  • Pediatric tuberculosis is a significant public health concern requiring careful management.
  • Addressing challenges like drug resistance and co-infection is critical.
  • Future research in vaccines holds promise for better control strategies.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...